by Ken Kelley
The U.S. Food and Drug Administration (FDA) is now reviewing a proposal by a Massachusetts company, AquaBounty Technologies, to sell genetically engineered salmon, which grow twice as fast as wild fish. If approved, it would be the first transgenic animal to be allowed into the human food supply.
The fish, called AquAdvantage Salmon, were developed at AquaBounty’s hatchery in Prince Edward Island, Canada. They are Atlantic salmon with an added growth hormone from the faster growing Chinook salmon. Engineers additionally inserted a gene from an eel-like fish called the ocean pout into the salmon, which activates the growth hormone and keeps the fish growing all year long.
Continue reading “FDA Prepares to Unleash Genetically Engineered Salmon on World”